BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4831127)

  • 1. Spironolactone and testicular cytochrome P-450: decreased testosterone formation in several species and changes in hepatic drug metabolism.
    Menard RH; Stripp B; Gillette JR
    Endocrinology; 1974 Jun; 94(6):1628-36. PubMed ID: 4831127
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone and cytochrome P-450: impairment of steroid 21-hydroxylation in the adrenal cortex.
    Menard RH; Bartter FC; Gillette JR
    Arch Biochem Biophys; 1976 Apr; 173(2):395-402. PubMed ID: 1275497
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of chronic treatment with phenobarbital or 3-methylcholanthrene on the male reproductive system in rats.
    Stripp B; Menard RH; Gillette JR
    Life Sci; 1974 Jun; 14(11):2121-30. PubMed ID: 4847804
    [No Abstract]   [Full Text] [Related]  

  • 4. Specificity of the in vitro destruction of adrenal and hepatic microsomal steroid hydroxylases by thiosteroids.
    Menard RH; Guenthner TM; Taburet AM; Kon H; Pohl LR; Gillette JR; Gelboin HV; Trager WF
    Mol Pharmacol; 1979 Nov; 16(3):997-1010. PubMed ID: 119158
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. Requirement for the 7alpha-thio group and evidence for the loss of the heme and apoproteins of cytochrome P-450.
    Menard RH; Guenthner TM; Kon H; Gillette JR
    J Biol Chem; 1979 Mar; 254(5):1726-33. PubMed ID: 762169
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of steroids on drug metabolism in male and female rats.
    Stripp B; Menard RH; Zampaglione NG; Hamrick ME; Gillette JR
    Drug Metab Dispos; 1973; 1(1):216-23. PubMed ID: 4149385
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential control of adrenal drug and steroid metabolism in the guinea pig.
    Greiner JW; Kramer RE; Rumbaugh RC; Colby HD
    Life Sci; 1977 Mar; 20(6):1017-26. PubMed ID: 191706
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
    List A; Nazar B; Nyquist S; Harclerode J
    Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-speed preparation of microsomes from testis, ovary and adrenal: a comparative study.
    Warchol A; Rembiesa R
    Steroids Lipids Res; 1974; 5(2):113-7. PubMed ID: 4428488
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of trypsin and phospholipases A2 and C on enzyme organization in testis microsomes.
    Bussmann L; Huseby RA; Samuels LT
    Mol Cell Endocrinol; 1976 Dec; 6(2):91-104. PubMed ID: 187506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intratesticular localization of cytochrome P-450 and cytochrome P-450-dependent enzymes in the rat testis.
    Menard RH; Latif SA; Purvis JL
    Endocrinology; 1975 Dec; 97(6):1587-92. PubMed ID: 1204579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
    Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of spironolactone by adrenocortical and hepatic microsomes: relationship to cytochrome P-450 destruction.
    Sherry JH; O'Donnell JP; Flowers L; Lacagnin LB; Colby HD
    J Pharmacol Exp Ther; 1986 Mar; 236(3):675-80. PubMed ID: 3950869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone and cytochrome P-450: impairment of steroid hydroxylation in the adrenal cortex.
    Menard RH; Martin HF; Stripp B; Gillette JR; Bartter FC
    Life Sci; 1974 Nov; 15(9):1639-48. PubMed ID: 4550000
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced destruction of cytochrome P-450.
    De Matteis F
    Drug Metab Dispos; 1973; 1(1):267-74. PubMed ID: 4149393
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional differences in adrenal activation of spironolactone: relationship to steroid 17 alpha-hydroxylase activity.
    Sherry JH; Johnson PB; Levitt M; Bergstrom J; Colby HD
    Drug Metab Dispos; 1989; 17(6):709-10. PubMed ID: 2575513
    [No Abstract]   [Full Text] [Related]  

  • 19. Localization of enzymes involved in testosterone biosynthesis by the mouse testis.
    Samuels LT; Matsumoto K
    Endocrinology; 1974 Jan; 94(1):55-60. PubMed ID: 4808892
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiplicity of testosterone hydroxylases in a reconstituted hepatic cytochrome P-450 system from uninduced male rats.
    Shiverick KT; Neims AH
    Drug Metab Dispos; 1979; 7(5):290-5. PubMed ID: 40768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.